Please try another search
StemLife Berhad, an investment holding company, provides end-to-end stem cell banking services to new born babies in Malaysia. The company engages in the collection, testing, processing, and preservation of umbilical cord blood stem cells (UCBSC), umbilical cord tissue (UCT), Wharton Jelly (WJ), and peripheral blood stem cells (PBSC) services. It also offers stem cell therapy and consultancy services. In addition, the company engages in harvesting, testing, processing, and preservation of UCT, WJ, and PBSC, as well as invests in properties. It provides umbilical cord blood-derived stem cells for bone marrow transplantation in paediatric leukemia and adult stem cells for use in treatment of blood-related disorders, heart disease, foot ulcers, and sports and trauma injuries. The company was founded in 2001 and is headquartered in Kuala Lumpur, Malaysia. StemLife Berhad is a subsidiary of Cordlife Group Limited.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review